Chromophobe renal cell carcinoma (CHRC) is a neoplasm of the kidney with clinicopathologic peculiarities that seems to be of better prognosis than conventional renal cell carcinoma. Classical and eosinophilic types are the two histological variants recorded. Also, it has been described in association with carcinoma of collecting ducts, conventional renal cell carcinoma and sarcomatoid renal cel...

herein, we report the f-18 fluorodeoxyglucose (18f-fdg) positron emission tomography (pet)/computed tomography (ct) findings of a benign solitary fibrous tumor (sft) of the kidney. the patient was a 63-year-old woman with a mass in the right kidney (10×9.7 cm), incidentally found on ct images. the ct scan showed a lobulated tumor arising from the hilum of the right kidney. the tumor consisted o...

Occurrence of multiple primary malignant tumors is very uncommon .Co occuring can be synchronous or non synchronous.Tumors presenting within a period less than equal to 6 months are called and if they occur after termed as metachronous. Synchronous malignancies rarer For defining both the should show criteria malignancy, possibility metastasis must have been ruled out pathologically distinct. B...

We report a case of simultaneous contralateral renal transitional cell carcinoma and renal cell carcinoma. A 63-yr-old male presented with hematuria. He was diagnosed with left renal pelvis tumor and contralateral renal cell carcinoma. Subsequently, the patient received left nephrectomy and paraaortic lymphadenectomy (transitional cell carcinoma, pT3N2M0). Post-operatively, chemotherapy of rena...

The standard therapy for thyroid cancer is total or near total thyroidectomy, followed by the administration of radioactive iodine for remnant ablation or residual disease. Patients with radioiodine therapy are predisposed to second malignant neoplasms in organs such as central nervous system (CNS), breast, prostate, kidney, bone marrow, salivary gland, and digestive tract. Exposure to carcinog...

AIMS Chromosome 3p deletions and loss of heterozygosity (LOH) for 3p markers are features of clear cell renal cell carcinoma but are rare in non-clear cell renal cell carcinoma. The VHL tumour suppressor gene, which maps to 3p25, is a major gatekeeper gene for clear cell renal cell carcinoma and is inactivated in most sporadic cases of this disease. However, it has been suggested that inactivat...

Introduction: Renal Cell Carcinoma (RCC) is the most common type of kidney cancer, accounting for 3% all malignancies and 85% malignant tumors. The histological classification utmost importance, considering significant prognostic therapeutic implications these subtypes. Here we report rare variant RCC which include Oncocytic papillary renal cell carcinoma (OPRCC). Case report: A middle age male...

Renal hydatid cyst is a rare entity as compared to hepatic cyst. However, literature manifests case reports of renal cysts. The establishment diagnosis becomes difficult in non-endemic areas. tumour well-considered on clinical examination and radiological investigations for this condition. We presented 45-yearsold male patient who with hematuria was labelled cell carcinoma clinically radiologic...

Background: Currently, the expression of HDAC6 in renal cell carcinoma has not yet been reported. Only little is known about the relationship between HDAC6 and clinical features of renal cell carcinoma as well. This study is aimed to verify the correlation between the expression of HDAC6 and clinical features of the patients with renal cell carcinoma. Methods: 90 patients with renal cell carcin...